ConsumerLab.com
This article was originally published in The Tan Sheet
Executive Summary
Fourteen of 20 omega-3 fatty acid supplements contain amount of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) listed on labeling, online testing firm announces Nov. 19. Six remaining products contained inadequate amounts of DHA, two also were low in EPA, ConusmerLab says. None of the products showed evidence of decomposition and none were found to contain detectable levels of mercury, a concern with fish oil products. Passing supplements include Nature's Way Neuromins, Solgar Omega-3 "700" EPA & DHA...
You may also be interested in...
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.
Biden Administration Is Setting An Example For Safe AI Use In Federal Organizations
A new memorandum by the Director of the Office of Management and Budget initiated a government-wide policy that will appoint AI officers to all agencies to address risks for AI use and serve as an example for greater AI adoption.